Page last updated: 2024-11-02

pioglitazone and Infarct

pioglitazone has been researched along with Infarct in 1 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Research Excerpts

ExcerptRelevanceReference
"PPARĪ³ agonist pioglitazone pretreatment significantly reduces infarct volume and attenuates neurological deficits following spinal cord ischemia."3.80A peroxisome proliferator-activated receptor gamma agonist attenuates neurological deficits following spinal cord ischemia in rats. ( Han, S; Hwang, J; Kim, H; Lim, C; Min, S; Nahm, SF; Park, K; Park, S, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kim, H1
Hwang, J1
Park, S1
Nahm, SF1
Min, S1
Lim, C1
Park, K1
Han, S1

Other Studies

1 other study available for pioglitazone and Infarct

ArticleYear
A peroxisome proliferator-activated receptor gamma agonist attenuates neurological deficits following spinal cord ischemia in rats.
    Journal of vascular surgery, 2014, Volume: 59, Issue:4

    Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Disease Models, Animal; Infarction; Inflammation; M

2014